These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2219450

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
    Schorlemmer HU, Bosslet K, Sedlacek HH.
    Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
    [Abstract] [Full Text] [Related]

  • 27. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
    Chen AR, McKinnon KP, Koren HS.
    J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
    [Abstract] [Full Text] [Related]

  • 28. Taxol provides a second signal for murine macrophage tumoricidal activity.
    Manthey CL, Perera PY, Salkowski CA, Vogel SN.
    J Immunol; 1994 Jan 15; 152(2):825-31. PubMed ID: 7506736
    [Abstract] [Full Text] [Related]

  • 29. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S, Weyers M, Gong JH, Sprenger H, Nain M, Gemsa D.
    J Immunol; 1988 Mar 01; 140(5):1511-8. PubMed ID: 3126228
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE, Talmadge JE, Fidler IJ.
    J Reticuloendothel Soc; 1983 Mar 01; 33(3):165-74. PubMed ID: 6834360
    [Abstract] [Full Text] [Related]

  • 37. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
    Pfannes SD, Müller B, Körner S, Bessler WG, Hoffmann P.
    J Leukoc Biol; 2001 Apr 01; 69(4):590-7. PubMed ID: 11310845
    [Abstract] [Full Text] [Related]

  • 38. Tumoricidal effector mechanisms of murine BCG-activated macrophages. I. Parameters of production and initial characterization of a cytolytic factor serologically related to necrosin.
    Klostergaard J, Foster WA, Leroux ME.
    J Biol Response Mod; 1987 Jun 01; 6(3):313-30. PubMed ID: 3298554
    [Abstract] [Full Text] [Related]

  • 39. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT, Eisenthal A, Rosenberg SA.
    J Immunol; 1988 Jun 01; 140(11):4062-9. PubMed ID: 3259603
    [Abstract] [Full Text] [Related]

  • 40. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
    Nii A, Fidler IJ.
    Lymphokine Res; 1990 Jun 01; 9(2):113-24. PubMed ID: 2338840
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.